GLP1R and hydrops fetalis: Over a median follow-up time of 1.6 years (IQR = 0.6–2.9), event rates for the primary outcome (HF hospitalization or CV death) in the overall cohort for patients receiving vs. not receiving GLP-1 RA were 15.7 vs. 19.4/100 patient-years, respectively (Figure 2, see Supplementary material online, Table S3 and Figure S5).